Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · T. Rowe Price

QAAHBX Expense Ratio & Fees

Ticker QAAHBX · Since 2002-04-30 · · Holdings as of Jun 30, 2026

Expense ratio
1.11%$111/yr per $10k
5-yr return
+3.9%annualized
1-yr return
+17.8%as of Dec 2025
Net assets
$751.7Mall share classes
Holdings
277

Bottom line

What is QAAHBX's expense ratio?

QAAHBX's expense ratio is 1.11%, or about $111 a year on every $10,000 invested. That is more expensive than 64% of health care sector funds we track (median 0.96%). Its expense ratio includes a 0.25% 12b-1 marketing fee.

Updated Apr 24, 2026

QAAHBX fee table

Net expense ratio1.11%
Gross expense ratio1.11%
Management fee0.65%
12b-1 (distribution) fee0.25%
Other expenses0.21%
Max front-end sales loadNone (ETF)

Source: Fund prospectus fee table, filed Apr 24, 2026

What QAAHBX costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
QAAHBX$113$353$612$1,352

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 1.11% expense ratio costs roughly $60,900 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).

Cheaper alternatives to QAAHBX

These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.

FundExpense ratioSaves per yearSaves over 20 yrs*Overlap
XLV SPDR (State Street)0.08%$103$5,60880%
FHLC Fidelity0.084%$103$5,58479%
VHT Vanguard0.09%$102$5,54979%
IYH iShares0.37%$74$3,92377%
JDOC J.P. Morgan0.65%$46$2,37658%

*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.

Cheapest way to own T. Rowe Price Health Sciences Portfolio

All share classes
TickerClassExpense ratioFront load
QAAGZXT. Rowe Price Health Sciences Portfolio0.86%None
QAAHBXT. Rowe Price Health Sciences Portfolio-II1.11%None